What proportion of opioid overdose deaths involve prescription opioids?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Opioid Overdose Deaths: Prescription vs. Illicit Opioids

Of the nearly 47,000 opioid overdose deaths in 2017, approximately 17.4% (roughly 8,200 deaths) involved prescription opioids only, while the vast majority—58.7% (approximately 27,600 deaths)—involved illicit opioids only, and 18.5% (approximately 8,700 deaths) involved both prescription and illicit opioids. 1

Understanding the Breakdown

The 2017 mortality data reveals a critical shift in the opioid epidemic:

  • Total opioid deaths in 2017: 47,600 out of 70,237 total drug overdose deaths (67.8%) 2
  • Prescription opioids only: 17.4% of opioid deaths 1
  • Illicit opioids only: 58.7% of opioid deaths 1
  • Both prescription and illicit opioids: 18.5% of opioid deaths 1
  • Unclassified: 5.5% could not be categorized 1

The Evolving Epidemic

The prescription opioid component represents a minority of current opioid deaths, with illicitly manufactured fentanyl (IMF) and heroin driving the majority of fatalities. 1, 3

Key Temporal Trends:

  • From 2017 to 2018, deaths involving prescription opioids decreased by 13.5%, while deaths involving synthetic opioids (primarily IMF) increased by 10% 3
  • By January-June 2018, IMF was involved in approximately two-thirds of all opioid deaths 4
  • The sharp increase in synthetic opioid deaths in 2014 coincided with increased availability of illicitly manufactured fentanyl, which increased by 80% between 2013 and 2014 5

Critical Clinical Context

Polysubstance involvement substantially increases mortality risk. 2, 4

  • Benzodiazepines were present in 62.6% of all opioid deaths in 2018, increasing death rates 3- to 10-fold compared to opioids alone 2
  • During January-June 2018,62.6% of all opioid deaths co-occurred with at least one common nonopioid drug (benzodiazepines, cocaine, or methamphetamine) 4
  • In North Carolina data, benzodiazepines were prescribed in the past year for 80% of decedents and were involved in 61% of deaths involving opioid pain medications 6

Geographic Distribution

The hardest-hit states in 2017 were concentrated in Appalachia and the Northeast 2:

  • West Virginia: 51.5 per 100,000
  • Delaware: 43.8 per 100,000
  • Maryland: 37.2 per 100,000
  • Pennsylvania: 36.1 per 100,000
  • Ohio: 35.9 per 100,000
  • New Hampshire: 35.8 per 100,000

Common Pitfalls in Interpretation

Do not assume "prescription opioid deaths" means legally prescribed medications. 5 Death certificates cannot distinguish between legitimately prescribed opioids, diverted prescription opioids, or illicitly manufactured fentanyl pressed into counterfeit prescription pills. 4 The CDC historically characterized all opioid pain reliever deaths as "prescription" opioid overdoses, but this classification has become increasingly problematic as IMF is pressed into counterfeit pills resembling prescription medications. 5

Bystanders were present in approximately 40% of deaths, yet naloxone was rarely administered by laypersons. 1 This represents a critical missed opportunity for intervention and underscores the need for expanded naloxone distribution and training. 1

References

Guideline

Opioid-Related Mortality in the United States

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.

MMWR. Morbidity and mortality weekly report, 2020

Research

Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.

MMWR. Morbidity and mortality weekly report, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.